<p>The present invention relates to compounds and pharmaceutically acceptable salts thereof and formulations comprising the compounds or a pharmaceutically acceptable salts thereof that are useful in methods of preventing pancreatic beta cell degeneration or methods of treating a disorder associated with pancreatic beta cell degeneration, such as type I diabetes.</p>
申请公布号
WO2011150300(A1)
申请公布日期
2011.12.01
申请号
WO2011US38278
申请日期
2011.05.27
申请人
MELIOR PHARMACEUTICALS I, INC.;REAUME, ANDREW, G.;SAPORITO, MICHAEL, S.;OCHMAN, ALEXANDER, R.
发明人
REAUME, ANDREW, G.;SAPORITO, MICHAEL, S.;OCHMAN, ALEXANDER, R.